Table 3.
References | Country | Time horizon | Population | Approach | Results |
---|---|---|---|---|---|
[52] | Canada | 1992–2001 | Incidence T2D pts from Saskatchewan Health’s administrative database in Canada | Sum-all medical | Highest total healthcare costs at year of diagnosis with CAN$7,343 ($7,635), then increased from a low of CANS$3,880 ($4,034) 3 years after diagnosis to CAN$4,441 ten years thereafter ($4,618) |
[19] | Colombia | 32 years | Hypothetical average Columbian T2D pt | Sum-all medical | Total lifetime costs (32-year period) of average diabetes pt, including direct and indirect costs, 57.565 million Colombian pesos ($54,351) |
[21] | Germany | 1995–2003 | Newly diagnosed T2D pts from randomly drawn practices across Germany | Sum-all medical | €1,288 ($1,635) for the first treatment year after diabetes diagnosis and increased to €3,845 ($4,880) in the 7th year |
[73] | USA | 1997–1998 | Women employed by nationwide operating company and hypothetical women above age 64 receiving Medicare | RB/matching | $282,973 incremental lifetime direct healthcare costs, using incidence-based, steady-state methodology |
pt(s) patient(s), RB regression based, T2D type 2 diabetes